$3.2 million NIH grant aims to correct diagnostic errors for breast cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In a new UCLA-led study, funded by a $3.2 million NCI grant, researchers will examine how perception and cognition interact in the interpretation of breast biopsy images. The aim is to improve physicians’ diagnostic skills and accuracy.

Joann Elmore, a UCLA Jonsson Comprehensive Cancer Center member and professor of medicine in the David Geffen School of Medicine at UCLA, is leading the five-year project which will study diagnostic errors made by residents in training as well as experienced pathologists.

“Pathologists want to be better at their job and find every suspicious lesion, but when they do make errors, it can be hard to know why,” said Elmore, who is also director of the UCLA National Clinician Scholars Program. “This project will use advanced eye-tracking techniques that measure exactly where the pathologist was looking during each case so that we can determine what is leading to diagnostic errors.”

Elmore’s previous research has identified high levels of disagreement and errors among physicians in the diagnosis of cancer.

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login